Novavax seeks Taiwan FDA emergency use nod for COVID-19 vaccine Ruchika Sharma14 May 2022 10:00 AM ISTUnited States: Novavax has announced the submission of a request for emergency use authorization to Taiwan's Food and Drug Administration for its...
Novavax seeks UK nod for Nuvaxovid use in adolescents aged 12 through 17 years Ruchika Sharma5 May 2022 11:00 AM ISTNVX-CoV2373 contains purified protein antigen and can neither replicate, nor can it cause COVID-19.
Early trial of Novavax COVID-Influenza vaccine shows promise Ruchika Sharma23 April 2022 10:00 AM ISTThe safety and tolerability profile of the combination vaccine was consistent with the stand-alone NVX-CoV2373 and quadrivalent nanoparticle influenza...
SII, Novavax get emergency use nod for Covovax in Thailand Ruchika Sharma12 April 2022 10:00 AM ISTCovovax is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novavax COVID vaccine gets nod in Canada Ruchika Sharma18 Feb 2022 1:02 PM ISTGaithersburg: Novavax, Inc. has recently announced that Health Canada has granted authorization for Nuvaxovid COVID-19 Vaccine (Recombinant protein,...
SII, Novavax get WHO EUL for Covovax Ruchika Sharma18 Dec 2021 2:32 PM ISTGaithersburg: Novavax, Inc. and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine manufacturer by volume, have announced that the...
Novavax seeks interim authorization of COVID vaccine in Singapore Ruchika Sharma28 Nov 2021 10:00 AM ISTGaithersburg: Novavax, Inc. has recently announced its submission to the Singapore Health Sciences Authority (HSA) for interim authorization of...
Serum Institute allowed to export 5 crore Covovax doses to Indonesia Ruchika Sharma16 Nov 2021 11:00 AM ISTNew Delhi: The Indian government has permitted export of 5 crore doses of Covovax, a COVID-19 vaccine domestically produced here by the Serum...
Novavax files for COVID vaccine EUL with WHO Ruchika Sharma8 Nov 2021 12:42 PM ISTGaithersburg: Novavax, Inc. has recently announced the completion of its rolling submission to the World Health Organization (WHO) for emergency use...
Novavax, Serum Institute seek DCGI emergency use nod for recombinant nanoparticle COVID vaccine Medical Dialogues Team7 Aug 2021 11:30 AM ISTNew Delhi: Novavax, a biotechnology company developing next-generation vaccines for serious infectious diseases, with its partner, Serum Institute of...
Novavax COVID-19 vaccine effective against B.1.351 variant of South Africa: NEJM Dr Satabdi Saha9 May 2021 11:15 PM ISTIn a recent development, researchers have highlighted that the NVX-CoV2373 vaccine is efficacious in preventing Covid-19, caused specifically by ...
Novavax begins COVID-19 vaccine clinical trial crossover Ruchika Sharma6 April 2021 1:30 PM ISTGaithersburg: Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, has recently announced the...
